Characterization of thalassemia major and diabetes mellitus patients at a reference center in Brazil

This is a quantitative transversal study that aimed to analyze the sociodemographic and clinical characteristics of thalassemia major patients with and without diabetes mellitus. The cohort consisted of 31 thalassemia major patients from a reference center of treatment in Brazil in 2016. The data we...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hematology, Transfusion and Cell Therapy Transfusion and Cell Therapy, 2019-04, Vol.41 (2), p.139-144
Hauptverfasser: Olivatto, Gabriela Marsola, Teixeira, Carla Regina de Souza, Sisdelli, Marcela Ganzella, Zanetti, Maria Lúcia, Silveira, Renata Cristina de Campos Pereira, Gonçalves, Claudio Vinicius
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This is a quantitative transversal study that aimed to analyze the sociodemographic and clinical characteristics of thalassemia major patients with and without diabetes mellitus. The cohort consisted of 31 thalassemia major patients from a reference center of treatment in Brazil in 2016. The data were obtained from an interview using a questionnaire containing demographic and clinical variables. The results show that 16.1% of the participants with thalassemia major had diabetes mellitus. The participants’ ages ranged from 20 to 48 years, with an average of 35 years, mostly students and starting in the formal job market. The most commonly used treatment was the oral desferasirox and the transfusion treatment interval was 15–22 days. Patients with thalassemia major and diabetes mellitus presented altered values of fasting glycemia, serum alanine transaminase, magnetic resonance imaging and bone densitometry. It was concluded that knowledge of the characteristics of this population contributes in the proposal of effective educational strategies in light of the complexity of care and the progression of the disease.
ISSN:2531-1379
2531-1387
2531-1387
DOI:10.1016/j.htct.2018.08.005